Bio-RadMarch 7, 2023

FDA 483 - Bio-Rad - March 07, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Bio-Rad

Record Details

Bio-Rad in Steenvoorde, France, was cited for multiple deficiencies related to its manufacturing processes and quality system for biologic IVD and biologic substance products. Observations included unapproved production procedures, inadequate documentation of acceptance activities, and failures in corrective and preventive actions. The inspection also found issues with the use of expired materials and insufficient equipment calibration.

Company: Bio-Rad
Inspection Date: March 7, 2023
Product Type: Biologics
Office: International Compliance Team
People: Elias N. Paz Alonzo
Meiling Liu
Richard T. Riggie (investigator)
Gene D. Arcy

Open in Dashboard

ID · 4680bd26-3bac-49ee-8e47-18b79e63a1d0